147 related articles for article (PubMed ID: 27819670)
21. Th22 cell accumulation is associated with colorectal cancer development.
Huang YH; Cao YF; Jiang ZY; Zhang S; Gao F
World J Gastroenterol; 2015 Apr; 21(14):4216-24. PubMed ID: 25892871
[TBL] [Abstract][Full Text] [Related]
22. Deletion in HSP110 T
Kim KJ; Lee TH; Kim JH; Cho NY; Kim WH; Kang GH
Hum Pathol; 2017 Sep; 67():109-118. PubMed ID: 28811251
[TBL] [Abstract][Full Text] [Related]
23. Hsp105beta upregulates hsp70 gene expression through signal transducer and activator of transcription-3.
Yamagishi N; Fujii H; Saito Y; Hatayama T
FEBS J; 2009 Oct; 276(20):5870-80. PubMed ID: 19754877
[TBL] [Abstract][Full Text] [Related]
24. Activation of the JAK-STAT3 pathway is associated with the growth of colorectal carcinoma cells.
Wei X; Wang G; Li W; Hu X; Huang Q; Xu K; Lou W; Wu J; Liang C; Lou Q; Qian C; Liu L
Oncol Rep; 2014 Jan; 31(1):335-41. PubMed ID: 24253664
[TBL] [Abstract][Full Text] [Related]
25. Differential, stage-dependent expression of Hsp70, Hsp110 and Bcl-2 in colorectal cancer.
Hwang TS; Han HS; Choi HK; Lee YJ; Kim YJ; Han MY; Park YM
J Gastroenterol Hepatol; 2003 Jun; 18(6):690-700. PubMed ID: 12753152
[TBL] [Abstract][Full Text] [Related]
26. HSP110 T17 simplifies and improves the microsatellite instability testing in patients with colorectal cancer.
Buhard O; Lagrange A; Guilloux A; Colas C; Chouchène M; Wanherdrick K; Coulet F; Guillerm E; Dorard C; Marisa L; Bokhari A; Greene M; El-Murr N; Bodo S; Muleris M; Sourouille I; Svrcek M; Cervera P; Blanché H; Lefevre JH; Parc Y; Lepage C; Chapusot C; Bouvier AM; Gaub MP; Selves J; Garrett K; Iacopetta B; Soong R; Hamelin R; Garrido C; Lascols O; André T; Fléjou JF; Collura A; Duval A
J Med Genet; 2016 Jun; 53(6):377-84. PubMed ID: 26831756
[TBL] [Abstract][Full Text] [Related]
27. [Mutation of HSP110 in colorectal cancer: the chaperone paradox].
Garrido C; Collura A; Berthenet K; Lagrange A; Duval A
Med Sci (Paris); 2012 Jan; 28(1):9-10. PubMed ID: 22289816
[No Abstract] [Full Text] [Related]
28. PAC exhibits potent anti-colon cancer properties through targeting cyclin D1 and suppressing epithelial-to-mesenchymal transition.
Al-Qasem A; Al-Howail HA; Al-Swailem M; Al-Mazrou A; Al-Otaibi B; Al-Jammaz I; Al-Khalaf HH; Aboussekhra A
Mol Carcinog; 2016 Mar; 55(3):233-44. PubMed ID: 25641341
[TBL] [Abstract][Full Text] [Related]
29. Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activation.
Lei Y; Liu L; Zhang S; Guo S; Li X; Wang J; Su B; Fang Y; Chen X; Ke H; Tao W
Mol Cancer; 2017 Nov; 16(1):170. PubMed ID: 29126425
[TBL] [Abstract][Full Text] [Related]
30. Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser⁷²⁷ on STAT3 in prostate cancer cells.
Hsu FN; Chen MC; Lin KC; Peng YT; Li PC; Lin E; Chiang MC; Hsieh JT; Lin H
Am J Physiol Endocrinol Metab; 2013 Oct; 305(8):E975-86. PubMed ID: 23941877
[TBL] [Abstract][Full Text] [Related]
31. Nmi interacts with Hsp105β and enhances the Hsp105β-mediated Hsp70 expression.
Saito Y; Yukawa A; Matozaki M; Mikami H; Yamagami T; Yamagishi N; Kuga T; Hatayama T; Nakayama Y
Exp Cell Res; 2014 Sep; 327(1):163-70. PubMed ID: 25088258
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of STAT3/cyclinD1 pathway promotes chemotherapeutic sensitivity of colorectal caner.
Qin A; Yu Q; Gao Y; Tan J; Huang H; Qiao Z; Qian W
Biochem Biophys Res Commun; 2015 Feb; 457(4):681-7. PubMed ID: 25617735
[TBL] [Abstract][Full Text] [Related]
33. Tyr23 phosphorylation of Anxa2 enhances STAT3 activation and promotes proliferation and invasion of breast cancer cells.
Yuan J; Yang Y; Gao Z; Wang Z; Ji W; Song W; Zhang F; Niu R
Breast Cancer Res Treat; 2017 Jul; 164(2):327-340. PubMed ID: 28470457
[TBL] [Abstract][Full Text] [Related]
34. Valosin-containing protein (VCP) promotes the growth, invasion, and metastasis of colorectal cancer through activation of STAT3 signaling.
Fu Q; Jiang Y; Zhang D; Liu X; Guo J; Zhao J
Mol Cell Biochem; 2016 Jul; 418(1-2):189-98. PubMed ID: 27344168
[TBL] [Abstract][Full Text] [Related]
35. Hirsutinolide Series Inhibit Stat3 Activity, Alter GCN1, MAP1B, Hsp105, G6PD, Vimentin, TrxR1, and Importin α-2 Expression, and Induce Antitumor Effects against Human Glioma.
Miklossy G; Youn UJ; Yue P; Zhang M; Chen CH; Hilliard TS; Paladino D; Li Y; Choi J; Sarkaria JN; Kawakami JK; Wongwiwatthananukit S; Chen Y; Sun D; Chang LC; Turkson J
J Med Chem; 2015 Oct; 58(19):7734-48. PubMed ID: 26331426
[TBL] [Abstract][Full Text] [Related]
36. HIF-3α1 promotes colorectal tumor cell growth by activation of JAK-STAT3 signaling.
Xue X; Jungles K; Onder G; Samhoun J; Győrffy B; Hardiman KM
Oncotarget; 2016 Mar; 7(10):11567-79. PubMed ID: 26871465
[TBL] [Abstract][Full Text] [Related]
37. Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100.
Wang XY; Chen X; Manjili MH; Repasky E; Henderson R; Subjeck JR
Cancer Res; 2003 May; 63(10):2553-60. PubMed ID: 12750279
[TBL] [Abstract][Full Text] [Related]
38. Ursolic acid inhibits the growth of colon cancer-initiating cells by targeting STAT3.
Wang W; Zhao C; Jou D; Lü J; Zhang C; Lin L; Lin J
Anticancer Res; 2013 Oct; 33(10):4279-84. PubMed ID: 24122993
[TBL] [Abstract][Full Text] [Related]
39. Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway.
Ren D; Lin B; Zhang X; Peng Y; Ye Z; Ma Y; Liang Y; Cao L; Li X; Li R; Sun L; Liu Q; Wu J; Zhou K; Zeng J
Oncotarget; 2017 Jul; 8(30):49807-49823. PubMed ID: 28591704
[TBL] [Abstract][Full Text] [Related]
40. (E)-4-(3-(3,5-dimethoxyphenyl)allyl)-2-methoxyphenol inhibits growth of colon tumors in mice.
Zheng J; Park MH; Son DJ; Choi MG; Choi JS; Nam KT; Kim HD; Rodriguez K; Gann B; Ham YW; Han SB; Hong JT
Oncotarget; 2015 Dec; 6(39):41929-43. PubMed ID: 26474284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]